Thiopurines are commonly used in the treatment of acute lymphoblastic leukaemia and autoimmune conditions, can be limited by myelosuppression. The NUDT15 c.415C>T variant is strongly associated with thiopurine-induced myelosuppression, especially in Asians. The purpose of this study was to develop a fast and reliable genotyping method for NUDT15 c.415C>T and investigate the polymorphic distribution among different races in China. A single-tube multiplex real-time PCR assay for NUDT15 c.415C>T genotyping was established using allele-specific TaqMan probes. In 229 samples, the genotyping results obtained through the established method were completely concordant with those obtained by Sanger sequencing. The distributions of NUDT15 c.415C>T among 173 Han Chinese, 48 Miaos, 40 Kazakhs, and 40 Kirghiz were different, with allelic frequencies of 0.06, 0.02, 0.07, and 0, respectively. This method will provide a powerful tool for the implementation of the genotyping-based personalized prescription of thiopurines in clinical settings.
ElionGB.The purine path to chemotherapy. Science1989;
244:41–7
2.
KarranPAttardN.Thiopurines in current medical practice: molecular mechanisms and contributions to therapy-related cancer. Nat Rev Cancer2008;
8:24–36
3.
Gjuladin-HellonTIheozor-EjioforZGordonMAkobengAK.Azathioprine and 6-mercaptopurine for maintenance of surgically-induced remission in Crohn's disease. Cochrane Database Syst Rev2019;
8:CD010233
4.
TimmerAPattonPHChandeNMcDonaldJWMacDonaldJK.Azathioprine and 6-mercaptopurine for maintenance of remission in ulcerative colitis. Cochrane Database Syst Rev2016;
2016:CD000478
5.
BoothRAAnsariMTLoitETriccoACWeeksLDoucetteSSkidmoreBSearsMSyRKarshJ.Assessment of thiopurine S-methyltransferase activity in patients prescribed thiopurines: a systematic review. Ann Intern Med2011;
154:814–23
6.
GoldbergRIrvingPM.Toxicity and response to thiopurines in patients with inflammatory bowel disease. Expert Rev Gastroenterol Hepatol2015;
9:891–900
7.
SchmiegelowKNielsenSNFrandsenTLNerstingJ.Mercaptopurine/methotrexate maintenance therapy of childhood acute lymphoblastic leukemia: clinical facts and fiction. J Pediatr Hematol Oncol2014;
36:503–17
8.
YangJJLandierWYangWLiuCHagemanLChengCPeiDChenYCrewsKRKornegayNWongFLEvansWEPuiCHBhatiaSRellingMV.Inherited NUDT15 variant is a genetic determinant of mercaptopurine intolerance in children with acute lymphoblastic leukemia. J Clin Oncol2015;
33:1235–42
9.
ConnellWRKammMARitchieJKLennard-JonesJE.Bone marrow toxicity caused by azathioprine in inflammatory bowel disease: 27 years of experience. Gut1993;
34:1081–5
10.
HindorfULindqvistMHildebrandHFagerbergUAlmerS.Adverse events leading to modification of therapy in a large cohort of patients with inflammatory bowel disease. Aliment Pharmacol Ther2006;
24:331–42
11.
de BoerNKvan BodegravenAAJharapBde GraafPMulderCJ.Drug insight: pharmacology and toxicity of thiopurine therapy in patients with IBD. Nat Clin Pract Gastroenterol Hepatol2007;
4:686–94
12.
PosthumaEFWestendorpRGvan der Sluys VeerAKluin-NelemansJCKluinPMLamersCB.Fatal infectious mononucleosis: a severe complication in the treatment of Crohn's disease with azathioprine. Gut1995;
36:311–3
13.
CoulthardSHogarthL.The thiopurines: an update. Invest New Drugs2005;
23:523–32
14.
WangLNguyenTVMcLaughlinRWSikkinkLARamirez-AlvaradoMWeinshilboumRM.Human thiopurine S-methyltransferase pharmacogenetics: variant allozyme misfolding and aggresome formation. Proc Natl Acad Sci U S A2005;
102:9394–9
15.
HiggsJEPayneKRobertsCNewmanWG.Are patients with intermediate TPMT activity at increased risk of myelosuppression when taking thiopurine medications?Pharmacogenomics2010;
11:177–88
16.
RellingMVGardnerEESandbornWJSchmiegelowKPuiCHYeeSWSteinCMCarrilloMEvansWEHicksJKSchwabMKleinTE.Clinical pharmacogenetics implementation consortium guidelines for thiopurine methyltransferase genotype and thiopurine dosing: 2013 update. Clin Pharmacol Ther2013;
93:324–5
17.
Collie-DuguidESPritchardSCPowrieRHSluddenJCollierDALiTMcLeodHL.The frequency and distribution of thiopurine methyltransferase alleles in Caucasian and Asian populations. Pharmacogenetics1999;
9:37–42
18.
JungESChoiKWKimSWHübenthalMMuchaSParkJParkZEllinghausDSchreiberSFrankeAOhWYCheonJH.ZNF133 is associated with infliximab responsiveness in patients with inflammatory bowel diseases. J Gastroenterol Hepatol2019;
34:1727–35
19.
KimJHCheonJHHongSSEunCSByeonJSHongSYKimBYKwonSHKimSWHanDSYangSKKimWH.Influences of thiopurine methyltransferase genotype and activity on thiopurine-induced leukopenia in Korean patients with inflammatory bowel disease: a retrospective cohort study. J Clin Gastroenterol2010;
44:e242–8
20.
TakatsuNMatsuiTMurakamiYIshiharaHHisabeTNagahamaTMakiSBeppuTTakakiYHiraiFYaoK.Adverse reactions to azathioprine cannot be predicted by thiopurine S-methyltransferase genotype in Japanese patients with inflammatory bowel disease. J Gastroenterol Hepatol2009;
24:1258–64
21.
TakagiYSetoyamaDItoRKamiyaHYamagataYSekiguchiM.Human MTH3 (NUDT18) protein hydrolyzes oxidized forms of guanosine and deoxyguanosine diphosphates: comparison with MTH1 and MTH2. J Biol Chem2012;
287:21541–9
22.
YangSKHongMBaekJChoiHZhaoWJungYHarituniansTYeBDKimKJParkSHParkSKYangDHDubinskyMLeeIMcGovernDPLiuJSongK.A common missense variant in NUDT15 confers susceptibility to thiopurine-induced leukopenia. Nat Genet2014;
46:1017–20
23.
AkiyamaSMatsuokaKFukudaKHamadaSShimizuMNankiKMizunoSKiyoharaHAraiMSugimotoSIwaoYOgataHHisamatsuTNaganumaMMotobayashiMSuzukiKTakenakaKFujiiTSaitoENagahoriMOhtsukaKMochizukiMWatanabeMHashiguchiMKanaiT.Long-term effect of NUDT15 R139C on hematologic indices in inflammatory bowel disease patients treated with thiopurine. J Gastroenterol Hepatol2019;
34:1751–7
24.
ShahSAParadkarMDesaiDAshavaidTF.Nucleoside diphosphate-linked moiety X-type motif 15 C415T variant as a predictor for thiopurine-induced toxicity in Indian patients. J Gastroenterol Hepatol2017;
32:620–4
25.
WahlundMNilssonAKahlinAZBrolidenKMyrbergIHAppellMLBerggrenA.The role of TPMT, ITPA, and NUDT15 variants during mercaptopurine treatment of Swedish pediatric patients with acute lymphoblastic leukemia. J Pediatr2020;
216:150–7 e1
26.
RellingMVSchwabMWhirl-CarrilloMSuarez-KurtzGPuiCHSteinCMMoyerAMEvansWEKleinTEAntillon-KlussmannFGCaudleKEKatoMYeohAEJSchmiegelowKYangJJ.Clinical pharmacogenetics implementation consortium guideline for thiopurine dosing based on TPMT and NUDT15 genotypes: 2018 update. Clin Pharmacol Ther2019;
105:1095–105
Alicia RodríguezMRCórdobaJJAndradeMJ.Design of primers and probes for quantitative real-time PCR methods. Methods Mol Biol2015;
1275:31–56
30.
RudinSMarableMHuangRS.The promise of pharmacogenomics in reducing toxicity during acute lymphoblastic leukemia maintenance treatment. Genomics Proteomics Bioinf2017;
15:82–93
31.
FongWYHoCCPoonWT.Comparison of direct sequencing, real-time PCR-high resolution melt (PCR-HRM) and PCR-restriction fragment length polymorphism (PCR-RFLP) analysis for genotyping of common thiopurine intolerant variant alleles NUDT15 c.415C>T and TPMT c.719A>G (TPMT*3C). Diagnostics2017;
7:27
32.
HoCCFongWYLeeYHPoonWT.Novel tetra-primer ARMS-PCR assays for thiopurine intolerance susceptibility mutations NUDT15 c.415C>T and TPMT c.719A>G (TPMT*3C) in east Asians. Genes2017;
8:285
33.
MontgomeryJWittwerCTPalaisRZhouL.Simultaneous mutation scanning and genotyping by high-resolution DNA melting analysis. Nat Protoc2007;
2:59–66
34.
CandySWrightJGerberMAdamsGGerigMGoodmanR.A controlled double blind study of azathioprine in the management of Crohn's disease. Gut1995;
37:674–8
35.
MoriyamaTNishiiRPerez-AndreuV, YWKlussmannFAZhaoXLinTNHoshitsukiKNerstingJKihiraKHofmannUKomadaYKatoMMcCorkleRLiLKohKNajeraCRKhamSKIsobeTChenZChiewEKBhojwaniDJeffriesCLuYSchwabMInabaHPuiCHRellingMVManabeAHoriHSchmiegelowKYeohAEEvansWEYangJJ.NUDT15 polymorphisms alter thiopurine metabolism and hematopoietic toxicity. Nat Genet2016;
48:367–73
36.
TemlASchaeffelerEHerrlingerKRKlotzUSchwabM.Thiopurine treatment in inflammatory bowel disease: clinical pharmacology and implication of pharmacogenetically guided dosing. Clin Pharmacokinet2007;
46:187–208
37.
ZhuXChaoKLiMXieWZhengHZhangJXHuPJHuangMGaoXWangXD.Nucleoside diphosphate-linked moiety X-type motif 15 R139C genotypes impact 6-thioguanine nucleotide cut-off levels to predict thiopurine-induced leukopenia in Crohn's disease patients. World J Gastroenterol2019;
25:5850–61
38.
YaoYGLüXMLuoHRLiWHZhangYP.Gene admixture in the Silk Road region of China: evidence from mtDNA and melanocortin 1 receptor polymorphism. Genes Genet Syst2000;
75:173–8
39.
RuofuYYD.Preliminary analysis of genetic distance between seventeen nationalities in China. J Genet Genomics1983;
010:398–40
Supplementary Material
Please find the following supplemental material available below.
For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.
For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.
